President & CEOOfficers of the CorporationBoard of TrusteesFoundation BoardLeadership CouncilAbout Joslin ResearchAdvocacy & Gov't AffairsHistory
Managing DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsJoslin Clinical ResearchInfo for Healthcare ProfessionalsJoslin Clinical Guidelines50-Year Medalist Program
Make an AppointmentmyJoslin | Patient PortalAdult ClinicYoung Adult Transition CarePediatricsEye CareWeight Management ProgramsDO ITMental Health & CounselingReferring PhysiciansBillingAfrican American ProgramsAsian ClinicLatino Diabetes InitiativeAbout Joslin ResearchVolunteer for Clinical Research StudiesInfo for Healthcare ProfessionalsClinical Guidelines
Directory of Joslin InvestigatorsDiabetes Research Center Alumni ConnectionVolunteer for Clinical Research Studies
Media RelationsNews ReleasesInside JoslinSocial Media
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternationalHealthcare ProfessionalsCommercialization and VenturesJoslin Institute for Technology Translation (JITT)
Give NowHigh Hopes FundWays to GivePlanned GivingEventsGet InvolvedCorporate & Foundation SupportOur DonorsDevelopment Team

Diabetes Eye Research Trials and Achievements

The Beetham Eye Institute is the world leader in research to identify the causes of diabetic eye disease and to find new therapies to lessen the risks of visual loss.

Director Lloyd Paul Aiello, M.D. is chairperson of the Diabetic Retinopathy Clinical Research Network, which involves Joslin in nearly every major clinical trial of the treatment and prevention of diabetic retinopathy and macular edema in the United States. Click here to learn about the Joslin Section on Eye Research.

Recent clinical trials have included the evaluation of such innovative therapies as:

Enrolling in a Clinical Trial

Patients at the Beetham Eye Institute may be eligible to participate in clinical trials. For information on our clinical trials, call 617-732-2586.

Click here for information on current clinical trials that are looking for volunteers.

Joslin’s Beetham Eye Institute is named after William P. Beetham, M.D, who with founding director Lloyd M. Aiello, M.D., helped pioneer laser surgery for diabetic eye disease.

This procedure is the gold-standard treatment for advanced diabetic retinopathy worldwide and has helped hundreds of thousands of people with diabetes preserve their vision.

Page last updated: March 28, 2015